Olin Corporation (OLN)

Investment Committee Summary

Investment Thesis

Olin manufactures and distributes chemical products across the United States, Europe and international markets. Commodity chemistry is a spread business: the company sells at a price it does not set and buys feedstock and energy at a cost it does not control, so profit is the difference between two exogenous series applied to a largely fixed asset base. An operating margin near 1.1% states plainly where in that cycle the company currently sits — at or close to a trough, which is also why a headline forward earnings multiple carries very little information for this name today. At $17.89 on 9 September 2026 the shares are trading cheap to the engine's triangulated fair value (+38%), which makes the BUY a mean-reversion call rather than a growth call: it pays only if spreads normalise. What decides the outcome is that normalisation and the clock on it, because the balance sheet carries net debt of ~$3.1B whose service cost does not fall with the cycle. The most damaging risk is the arithmetic of that pairing — with margin this thin and leverage this fixed, the equity is a small residual on a volatile number.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($17.89) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The real bear case is that the trough is structural rather than cyclical. Commodity chemical capacity is added in large, indivisible blocks with long lead times, so it arrives after the price signal that justified it has already gone; if global demand growth is slower than the capacity already committed, spreads do not mean-revert, they reset lower and stay there. Against that outcome, the debt is fixed. Interest is paid before equity holders see anything, maintenance capital cannot be deferred indefinitely on a chemical asset base without safety and reliability consequences, and the dividend competes for the same shrinking cash flow. In that path the equity does not merely fall with earnings, it is geared to them: the operating margin near 1.1% moving toward zero removes most of the value before the multiple is even consulted. The model gives its structural branch the heaviest weight of any downside state, and targets a level below the 52-week low.

Key Debate

Gross Margin explains 49% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays -39.0× consensus forward EPS, and a peer median 12.9×.

Variant perception: the house view is above-consensus, and the thesis is primarily multiple-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Leverage / Overcapacity / Cost Shock' downside ($8.69) to a 'Peak — Cycle High + Multiple Re-rate' bull case ($51.32); the probability-weighted blend (PWEV $24.14) is +35% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.3% of revenue; free cash flow net of SBC is $0.23B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

Valuation Triangulation

Two weighted anchors — a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat two numbers as two independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts, peer P/E re-rate are not computed, so 60% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $25.50 and 76% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (49% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $63.38; the peer-median forward P/E is 12.9x, but the engine carries no P/E-implied price for this name (this name is valued on EV/EBITDA, so no P/E-implied price is carried). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 154% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Peer Quality & Weighting

Quality-weighted forward P/E: 12.9× (simple median 12.9×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $16.97–$30.25, centre $22.70 (+27% vs spot); spot sits at the 7th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Peak — Cycle High + Multiple Re-rate): $51.32.

Company Overview & Business Model

Olin Corporation — BASIC MATERIALS · CHEMICALS. Olin Corporation manufactures and distributes chemical products in the United States, Europe, and internationally. The company is headquartered in Clayton, Missouri.

How it makes money.

Edge. No identified moat — inferred from a 1.1% operating margin and the capital-intensive / levered business model. Commodity / cyclical economics; terminal multiple should sit at or below the market.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Materials — Commodity

This name sits in the Materials — Commodity cluster as a commodity & diversified chemicals name. petrochemical spreads (ethylene/PE/PP) + feedstock + global demand. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: CBT (commodity & diversified chemicals) · SMG (fertilizers (N / P / K)) · ASH (commodity & diversified chemicals) · OLN (commodity & diversified chemicals)

Mapping note: name-level 'Structural — Leverage / Overcapacity / Cost Shock' (24%) + 'Cyclical Downturn — Demand / Volume Recession' (20%) map to cluster Commodity Glut — Oversupply / Demand Reset (44%); name-level 'Upcycle — Strong Demand / Operating Leverage' (16%) + 'Peak — Cycle High + Multiple Re-rate' (8%) map to cluster Tight Market — Upcycle / Spike (24%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset — this name implies 44% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs. Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.62 vs analyst floor +0.00 → delta +0.62 (n=16 mgmt / 11 Q&A; 89th pctile across the S&P book, z +1.3).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

News (last 365d, 187 articles): avg ticker sentiment -0.01 (bullish 14% / bearish 17%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-26 (~48d) — Quarterly earnings — est. EPS $0.11 (AV EARNINGS_CALENDAR)

Forecast Track Record

• EPS surprise: beat 50% of the last 8 quarters; average surprise +57.3%.
• Prior-forecast backtest (18 snapshots, 2026-07-21→2026-09-03): directional hit-rate 11%; mean predicted +26.2% vs realised -6.5%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

5 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 1 bullish / 1 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
• FY revenue ($B) < 6.85 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
• Probability-weighted fair value (PWEV) at the next re-run < 17.89 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $17.89; 52-week range $16.97–$30.25; engine rating BUY; house target $24.14 (+35%). (source: Alpha Vantage 2026-09-08, 9 September 2026)
• INFERENCE: Triangulated FV $24.65 (+38% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

44.9/100 (confidence band 33.3–56.6), 8th percentile of 893 covered names (as of 2026-09-08). Weighted composite under config ros-1.20.0 — every component and its inputs below.

Score history: 45.3 → 45.3 → 44.9 → 45.3 → 44.7 → 45.7 → 44.9 → 45.2.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $24.14.

Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.42, vs QQQ +0.33 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Call Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• bullish with cheap options — buy defined-risk upside; a debit spread caps cost vs an outright call
• Direction bullish from the overlay conviction/rating (read-only input).
• IV/RV at the 23rd percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 50th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +5.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +5.8pp): 38-DTE 50% · 73-DTE 53% · 500-DTE 56%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: LEAPS, Long Stock. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the BUY equity view. Chain as of 2026-09-08 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 50.3% (moderate regime) · expected move ±12.2% (2026-10-16) · put/call OI 0.69 · ATM Δ 0.60 / Θ -0.01 / ν 0.02 · next earnings 2026-10-26. Direction: LONG (implied return +37.8% to triangulated fair value $24.65).

Bull Call Spread (Bullish) — Long 17.5 C / Short 25 C · 2027-02-19 · net debit $1.73 · max profit $5.78 · breakeven $19.23 · RoR 335.0% · max loss $1.73 · priced from the listed chain (EOD marks)

Defined-cost leverage to the fair-value gap: the debit is the entire downside, in exchange for participation between the strikes — directional exposure at a fraction of the outright call premium. Illustrative — no outcome is implied or guaranteed.

Long Call (LEAPS) (Bullish) — Long 17.5 C · 2027-02-19 · premium $2.33 · breakeven $19.82 · max loss $2.33 · priced from the listed chain (EOD marks)

Pure defined-risk directional exposure — the premium is the whole downside while the full upside is retained. A capped, known cost as an alternative to owning the shares outright.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = BUY because:

• Probability-weighted scenario value implies +35% vs spot
• Monte Carlo median implies +43% vs spot
• Bear case (Structural — Leverage / Overcapacity / Cost Shock) downside is -51% vs spot
• Net: reward/risk of 0.7× supports a Buy — note this is below 1.0×, i.e. the modelled downside exceeds the modelled upside despite the Buy rating.

Assumption Register

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

No DCF anchor is meaningful for this asset; the blend leans 62% on probability-weighted scenarios and 37% on the Monte Carlo median — the scenario probabilities are the load-bearing inputs.